Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-24-004304

Head of Pharm Ops and Tech gave up 638 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 2,101 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Murphy Nicole · Head of Pharm Ops and Tech

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-08 Exercise or conversion : show line 1 in the form +2,101 7,894.99 D
2024-02-08 Shares withheld for taxes : show line 2 in the form −638 $240.30 $153,311 7,256.99 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-02-07 Grant or award : show line 3 in the form Restricted Stock Unit +5,820 5,820 D
2024-02-08 Exercise or conversion : show line 4 in the form Restricted Stock Unit −2,101 4,204 D
Loading xslF345X05/form4.xml…